Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022044

Expand all

JANUMET (METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE)
500MG;EQ 50MG BASE Marketing Status: Prescription

Active Ingredient: METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
Proprietary Name: JANUMET
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG;EQ 50MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022044
Product Number: 001
Approval Date: Mar 30, 2007
Applicant Holder Full Name: MERCK SHARP AND DOHME CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

JANUMET (METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE)
1GM;EQ 50MG BASE Marketing Status: Prescription

Active Ingredient: METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
Proprietary Name: JANUMET
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1GM;EQ 50MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N022044
Product Number: 002
Approval Date: Mar 30, 2007
Applicant Holder Full Name: MERCK SHARP AND DOHME CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English